If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEagle Eye Regulatory News (EYE)

Share Price Information for Eagle Eye (EYE)

Share Price is delayed by 15 minutes
Get Live Data
475.00    0.00 (0.00%)
Bid:
470.00
Ask:
480.00
Spread: 10.00 (2.128%)
Market Cap: £143.57m
EYE Live PriceLast checked at - London Stock Exchange

Intraday Eagle Eye Share Chart

Director/PDMR Shareholding

12 Feb 2026 15:32

RNS Number : 8285S
Eagle Eye Solutions Group PLC
12 February 2026
 

12 February 2026

Eagle Eye Solutions Group PLC

 

("Eagle Eye" or the "Company")

 

PDMR Shareholding

 

Eagle Eye, a leading SaaS and AI technology company that creates digital connections enabling personalised, real-time marketing at scale, announces that it has been informed today that Zyed Jamoussi, Chief Technology Officer, has transferred 106,208 Ordinary Shares in the Company to a new custody account.

Following this transaction the beneficial interest of Zyed Jamoussi remains unchanged at 106,208 Ordinary Shares representing 0.35% of the issued Ordinary Share capital of the Company.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

 

Name

Zyed Jamoussi

2

Reason for the notification

a)

 

 

Position/status

Chief Technology Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eagle Eye Solutions Group plc

b)

LEI

2138002S1AIBVVMZ7A21

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 1p each

 

GB00BKF1YD83

b)

Nature of transaction

Transfer of custody account

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

106,208

Aggregated information

- Aggregated volume

- Price

n/a

 

e)

Date of the transaction

12 February 2026

 

f)

Place of the transaction

Outside of a trading venue

 

 

Enquiries:

Eagle Eye Solutions Group plc

Tel: 0844 824 3686

Tim Mason, Chief Executive Officer

 

Lucy Sharman-Munday, Chief Financial Officer

 

 

 

 

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Tel: +44 20 7523 8000

Simon Bridges, Harry Gooden, Andrew Potts, Elizabeth Halley-Stott

 

 

Shore Capital (Joint Broker)

Tel: +44 20 7408 4090

Corporate Advisory: Daniel Bush, David Coaten, Lucy Bowden

 

Corporate Broking: Henry Willcocks

 

 

 

 

Alma Strategic Communications

Tel: +44 20 3405 0205

Caroline Forde, Hannah Campbell, Kinvara Verdon

 

 

 

About Eagle Eye

Eagle Eye is a leading SaaS and AI company, enabling retail, travel and hospitality brands to earn lasting customer loyalty through harnessing the power of real-time, omnichannel and personalised marketing. Our powerful technology combines the world's most flexible and scalable loyalty and promotions capability with cutting edge, built-for-purpose AI to deliver 1:1 personalisation at scale for enterprise businesses, globally. 

 

Our growing customer base includes Loblaws, Southeastern Grocers, Giant Eagle, Asda, Tesco, Morrisons, JD Sports, E.Leclerc, Carrefour, the Woolworths Group and many more. Each week, more than 1 billion personalised offers are seamlessly executed via our platform, and over 700 million loyalty member wallets are managed worldwide.

 

AI-powered, API-based and cloud-native, Eagle Eye's enterprise-grade technology is fully certified by the MACH Alliance and has received recognition from leading industry bodies, including Gartner, Forrester, IDC and QKS.

 

Web - www.eagleeye.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHELLFFQLLLBBK
Date   Source Headline
18th Sep 20187:00 amRNSFinal Results
28th Aug 20187:00 amRNSNotice of Results
25th Jul 20187:00 amRNSTrading Update
28th Jun 20187:00 amRNSEagle Eye extends credit facility with Barclays
21st May 20187:00 amRNSDeath of a Director
10th May 20187:00 amRNSNew contract with Sainsbury's
11th Apr 201812:10 pmRNSDirector/PDMR Shareholding
4th Apr 20184:29 pmRNSDirector/PDMR Shareholding
13th Mar 201811:11 amRNSEagle Eye update on new Loblaw partner
13th Mar 20187:00 amRNSInterim Results
27th Feb 201812:00 pmRNSEagle Eye launches PC Optimum with Loblaw
5th Feb 20183:53 pmRNSIssue of Equity
23rd Jan 20187:00 amRNSTrading Update
19th Dec 20179:57 amRNSDirector Declaration
10th Nov 20174:03 pmRNSIssue of share options
9th Nov 20171:30 pmRNSResult of AGM
9th Nov 20177:00 amRNSAGM Statement
27th Oct 20174:56 pmRNSDirector/PDMR Shareholding
27th Oct 20179:58 amRNSDirector/PDMR Shareholding
12th Oct 20177:00 amRNS2017 Annual Report & Accounts and Notice of AGM
19th Sep 20176:14 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSFinal Results
16th Aug 20174:41 pmRNSNotice of Results
31st Jul 20177:00 amRNSNotification of Transactions by a Director/PDMR
31st Jul 20177:00 amRNSIssue of Equity
21st Jul 20176:06 pmRNSDirector/PDMR Shareholding
18th Jul 20172:07 pmRNSTrading Update - Replacement
18th Jul 20177:00 amRNSTrading Update
6th Jul 20177:00 amRNSEYE and TGCS sign renewed 2-year Asda contract
30th Jun 20173:26 pmRNSIssue of Equity
20th Jun 20177:00 amRNSIssue of Equity
12th Jun 201710:59 amRNSResult of General Meeting and Total Voting Rights
6th Jun 20179:33 amRNSIssue of Equity
1st Jun 201710:10 amRNSIssue of Equity
30th May 20179:55 amRNSIssue of Equity
26th May 20171:24 pmRNSUpdate on Placing
26th May 20171:03 pmRNSUpdate on Placing
26th May 20177:00 amRNSProposed Placing to raise up to £6.0 million
12th May 20177:00 amRNSEagle Eye signs 3 year contract with John Lewis
10th May 20177:00 amRNSAppointment of Chief Operating Officer
10th Apr 20177:00 amRNSIssue of Equity
7th Apr 201711:48 amRNSIssue of Equity
17th Mar 20173:15 pmRNSNotification of Transactions by a Director/PDMR
17th Mar 20173:06 pmRNSNotification of Transactions by a Director/PDMR
17th Mar 20172:50 pmRNSNotification of Transactions by a Director/PDMR
14th Mar 20177:02 amRNSEagle Eye and TCC Global in exclusive partnership
14th Mar 20177:00 amRNSInterim Results
21st Feb 20177:00 amRNSNotice of Interim Results
9th Feb 20177:00 amRNSIssue of Equity
6th Feb 20177:00 amRNSExtension of credit facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.